Global Cord Blood Corporation (NYSE:CO) Q2 2020 Earnings Conference Call - Final Transcript
Nov 27, 2019 • 08:00 am ET
CHEN Bing Chuen, Albert
year. As a result of an increase in operating income and a significant decrease in mark-to-market loss from equity securities, income before tax increased by 78% year-over-year to RMB144 million. Net income attributable to the Company's shareholders increased by 85% year-over-year to RMB120 million. Net margin improved to 38% from 26% of last year. Basic and diluted earnings per ordinary share for the second quarter were RMB0.99.
This concludes my remarks. We are now happy to take any questions concerning our latest financial results and our recent operational developments.